All stock lists
Tronox Holdings plc (New York Stock Exchange:TROX)
US · Delayed Price · Currency is USD
Basic Materials · Chemicals
2.61-0.94 (-26.48%)
Market cap
$417M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 1, 2010
Website
Insider Score
––Not scored
TROX Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TROX analyst forecast
TROX analyst consensus
Moderate Sell5 ratings
Buy 0 Hold 2 Sell 3
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TROX 12-month price target
$4.17+59.8% upsideaverage of 3 firms
$4.50High
$4.00Low
TROX ratings mix, last 12 months
Buy Hold Sell
Best analysts covering TROX
- Mizuho100%success rate · +7.4% avg return · 3 calls
- JP Morgan67%success rate · +44.3% avg return · 3 calls
- Truist Securities50%success rate · +17.6% avg return · 4 calls
- Goldman Sachs43%success rate · +13.5% avg return · 7 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TROX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Truist Securities | Hold | — | — | Reiterated | 2026-10-20 |
| Truist Financial | — | $4.00 | +18.7% | — | 2026-10-20 | |
| Goldman Sachs | Sell | $4.00 | +7.1% | Reiterated | 2026-10-12 | |
| UBS | Neutral | $4.50 | +14.5% | Reiterated | 2026-10-05 | |
| — | Mizuho | Underperform | — | — | Reiterated | 2026-09-30 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2026-08-13 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2026-07-22 |
| — | Truist Securities | Hold | — | — | Upgraded | 2026-06-11 |
| — | Goldman Sachs | Sell | — | — | Downgraded | 2026-05-12 |
| — | Truist Securities | Sell | — | — | Reiterated | 2026-05-08 |
| — | Truist Securities | Sell | — | — | Downgraded | 2026-04-28 |
| — | Truist Securities | Hold | — | — | Downgraded | 2026-04-09 |
| — | UBS | Neutral | — | — | Reiterated | 2026-04-09 |
| — | Mizuho | Underperform | — | — | Reiterated | 2026-03-23 |
| — | Mizuho | Underperform | — | — | Reiterated | 2026-03-05 |
| — | UBS | Neutral | — | — | Reiterated | 2026-02-26 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-01-29 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-01-29 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-01-21 |
| — | UBS | Neutral | — | — | Reiterated | 2026-01-12 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-12-16 |
| — | Mizuho | Underperform | — | — | Reiterated | 2025-12-10 |
| — | UBS | Neutral | — | — | Reiterated | 2025-11-11 |
| — | Mizuho | Underperform | — | — | Reiterated | 2025-11-06 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-10-20 |
| — | Mizuho | Underperform | — | — | Reiterated | 2025-10-16 |
| — | UBS | Neutral | — | — | Reiterated | 2025-10-06 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2025-10-03 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-09-16 |
| — | Mizuho | Underperform | — | — | Downgraded | 2025-09-12 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-08-07 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-08-06 |
| — | UBS | Neutral | — | — | Downgraded | 2025-08-04 |
| — | Mizuho | Neutral | — | — | Reiterated | 2025-07-15 |
| — | UBS | Buy | — | — | Reiterated | 2025-07-09 |
| — | BMO Capital | Underperform | — | — | Downgraded | 2025-06-30 |
| — | UBS | Buy | — | — | Reiterated | 2025-06-04 |
| — | JP Morgan | Overweight | — | — | Upgraded | 2025-05-30 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-05-28 |
| — | BMO Capital | Market Perform | — | — | Downgraded | 2025-05-07 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-05-06 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-05-05 |
| — | UBS | Buy | — | — | Reiterated | 2025-05-01 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-04-14 |
| — | Mizuho | Neutral | — | — | Reiterated | 2025-03-13 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-02-26 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-02-18 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-02-18 |
| — | UBS | Buy | — | — | Reiterated | 2025-02-13 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-01-13 |
| — | UBS | Buy | — | — | Reiterated | 2025-01-10 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-01-07 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-10-29 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-10-28 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-08-06 |
| — | UBS | Neutral | — | — | Reiterated | 2024-07-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-05-15 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-05-06 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-05-03 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2024-02-20 |
TROX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-18 | -0.43 | -0.60 | $708.0M | $730.0M |
| 2026-05-06 | -0.48 | -0.55 | $751.4M | $760.0M |
| 2026-08-05 | -0.38 | -0.51 | $832.6M | $868.0M |
| 2026-11-04 | -0.21 | -0.34 | $854.4M | $827.0M |
| 2027-02-17Upcoming | -0.26 | — | $790.4M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.